NEOPROBE CORP
S-3/A, EX-23.1, 2000-08-07
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEOPROBE CORP, S-3/A, 2000-08-07
Next: NEOPROBE CORP, S-3/A, EX-23.2, 2000-08-07



<PAGE>   1
                                                                    Exhibit 23.1

                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

The Board of Directors
Neoprobe Corporation:

We consent to the use of our report dated February 14, 2000 incorporated herein
by reference.


                                                          /s/ KPMG LLP

Columbus, Ohio
August 3, 2000

                                     II-5


26


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission